
Servaas Michielssens, Linden Thomson, Equities
25 Years of Innovation in Biotechnology: a Strategy Always at the Ccutting Edge
In 2000, Candriam took an audacious gamble : to invest in biotechnology, a field that was still little-followed by analysts at the time.